High frequencies of CD62L + naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation

Clinical and Experimental Immunology

Volumn 165, Issue 2, 2011, Pages 264-277

  Lu, S Y ^a   Liu, K Y ^a   Liu, D H ^a   Xu, L P ^a   Huang, X J ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Acute graft versus host disease; Allogeneic haematopoietic stem cell transplantation; Immune reconstitution; Immune tolerance; Regulatory T cell

Indexed keywords

BUSULFAN; CD45RA ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; L SELECTIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGRAFT; ARTICLE; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG MEGADOSE; FEMALE; HAZARD RATIO; HUMAN; MALE; MORBIDITY; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SIBLING; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; ANTIGENS, CD4; ANTIGENS, CD45; CHILD; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; L-SELECTIN; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 79960061627     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04418.x     Document Type: Article

References (50)

1. Socie G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood 2009; 114:4327-36.
2. Hess AD. Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol Blood Marrow Transplant 2006; 12:13-21.
3. Lu DP, Dong L, Wu T etal. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006; 107:3065-73.
4. Huang XJ, Liu DH, Liu KY etal. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006; 38:291-7.
5. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199-210.
6. Clave E, Busson M, Douay C etal. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 2009; 113:6477-84.
7. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 2007; 109:827-35.
8. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99:3493-9.
9. Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193:1295-302.
10. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193:1285-94.
11. Matthews K, Lim Z, Afzali B etal. Imbalance of effector and regulatory CD4 T cells is associated with graft versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. Haematologica 2009; 94:956-66.
12. Fondi C, Nozzoli C, Benemei S etal. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biol Blood Marrow Transplant 2009; 15:938-47.
13. Di Biaso I, Di Maio L, Bugarin C etal. Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. Transplantation 2009; 87:1422-5.
14. Rieger K, Loddenkemper C, Maul J etal. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 2006; 107:1717-23.
15. Mielke S, Rezvani K, Savani BN etal. Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood 2007; 110:1689-97.
16. Trzonkowski P, Bieniaszewska M, Juscinska J etal. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin Immunol 2009; 133:22-6.
17. Wang J, Zhang L, Tang J, Jiang S, Wang X. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination. Transplant Proc 2008; 40:1612-17.
18. Nguyen VH, Shashidhar S, Chang DS etal. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 2008; 111:945-53.
19. Cao T, Soto A, Zhou W etal. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD). Cell Immunol 2009; 258:65-71.
20. Noel G, Bruniquel D, Birebent B etal. Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells. Clin Immunol 2008; 129:241-8.
21. Noel G, Bruniquel D, DeGuibert S etal. Regulatory CD4+CD25hi T cells conserve their function and phenotype after granulocyte colony-stimulating factor treatment in human hematopoietic stem cell transplantation. Hum Immunol 2008; 69:329-37.
22. Lu SY, Huang XJ, Liu KY, Liu DH, Xu LP. CD4+CD25-CD69+ T cells is a novel subset of regulatory T cells involved in the prevention of acute graft-versus-host disease in human. Blood 2010; 116:536.
23. Hoffmann P, Eder R, Boeld TJ etal. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108:4260-7.
24. Taylor PA, Panoskaltsis-Mortari A, Swedin JM etal. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004; 104:3804-12.
25. Ermann J, Hoffmann P, Edinger M etal. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 2005; 105:2220-6.
26. Przepiorka D, Smith TL, Folloder J etal. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94:1465-70.
27. Zaucha JM, Gooley T, Bensinger WI etal. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98:3221-7.
28. Urbano-Ispizua A, Rozman C, Pimentel P etal. Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings. Blood 2002; 100:724-7.
29. Rezvani K, Mielke S, Ahmadzadeh M etal. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006; 108:1291-7.
30. Luo XH, Chang YJ, Xu LP, Liu DH, Liu KY, Huang XJ. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT. Bone Marrow Transplant 2009; 43:29-36.
31. Chang YJ, Zhao XY, Huo MR, Huang XJ. Expression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation. J Clin Immunol 2009; 29:696-704.
32. Glucksberg H, Storb R, Fefer A etal. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18:295-304.
33. Huang XJ, Jiang Q, Chen H etal. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 36:343-8.
34. Lu J, Xu LP, Huang XJ etal. [Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody]. Zhonghua Yi Xue Za Zhi 2003; 83:216-19.
35. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 2005; 115:1953-62.
36. Matsuoka K, Kim HT, McDonough S etal. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest 2010; 120:1479-93.
37. Seddiki N, Santner-Nanan B, Tangye SG etal. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 2006; 107:2830-8.
38. Tang Q, Adams JY, Tooley AJ etal. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006; 7:83-92.
39. Foster AE, Marangolo M, Sartor MM etal. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion. Blood 2004; 104:2403-9.
40. Carlson MJ, Fulton LM, Coghill JM etal. L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation. Am J Transplant 2010; 10:2596-603.
41. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
42. Zhang H, Chua KS, Guimond M etal. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med 2005; 11:1238-43.
43. Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004; 21:267-77.
44. Cozzo C, Larkin J III, Caton AJ. Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol 2003; 171:5678-82.
45. Ruzek MC, Waire JS, Hopkins D etal. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood 2008; 111:1726-34.
46. Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 2006; 107:1018-23.
47. Coenen JJ, Koenen HJ, van Rijssen E etal. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells. Bone Marrow Transplant 2007; 39:537-45.
48. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004; 4:665-74.
49. Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 2004; 172:6519-23.
50. Lim DG, Koo SK, Park YH etal. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation. Transplantation 2010; 89:928-36.